Harrow (HROW) Assets (2010 - 2026)
Harrow's (HROW) quarterly Assets came in at $419.5 million in Q1 2026, up 15.21% year-on-year from $364.2 million in Q1 2025, and up 5.02% quarter-over-quarter from $399.5 million in Q4 2025.
Harrow (HROW) Assets (2010 - 2026) Analysis & Trends
Harrow's Assets history runs 17 years deep, the most recent figure standing at $419.5 million for Q1 2026.
- On a quarterly basis, Assets rose 15.21% year-over-year to $419.5 million in Q1 2026; TTM through Mar 2026 was $419.5 million, a 15.21% increase from a year earlier, with the FY2025 full-year figure at $399.5 million, up 2.7% from the prior year.
- Assets climbed to $419.5 million in Q1 2026 per HROW's latest filing, from $399.5 million in the prior quarter.
- Across five years, Assets topped out at $419.5 million in Q1 2026 and bottomed at $97.6 million in Q1 2022.
- The 5-year median for Assets is $306.6 million (2024), against an average of $278.0 million.
- Across the five-year window, Assets dropped 8.32% in 2022 and surged 188.98% in 2023, its largest moves.
- Year by year, Assets stood at $157.4 million in 2022, then soared by 98.35% to $312.2 million in 2023, then rose by 24.6% to $389.0 million in 2024, then increased by 2.7% to $399.5 million in 2025, then increased by 5.02% to $419.5 million in 2026.
- Per Business Quant, the three latest HROW Assets figures stand at $419.5 million (Q1 2026), $399.5 million (Q4 2025), and $363.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 419.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 419.54 Mn |
| Dec 31, 2025 | 399.48 Mn |
| Sep 30, 2025 | 363.07 Mn |
| Jun 30, 2025 | 345.03 Mn |
| Mar 31, 2025 | 364.16 Mn |
| Dec 31, 2024 | 388.97 Mn |
| Sep 30, 2024 | 351.54 Mn |
| Jun 30, 2024 | 306.63 Mn |
| Mar 31, 2024 | 295.54 Mn |
| Dec 31, 2023 | 312.16 Mn |
| Sep 30, 2023 | 286.07 Mn |
| Jun 30, 2023 | 223.99 Mn |
| Mar 31, 2023 | 217.50 Mn |
| Dec 31, 2022 | 157.38 Mn |
| Sep 30, 2022 | 98.99 Mn |
| Jun 30, 2022 | 98.06 Mn |
| Mar 31, 2022 | 97.60 Mn |
| Dec 31, 2021 | 98.33 Mn |
| Sep 30, 2021 | 102.80 Mn |
| Jun 30, 2021 | 106.97 Mn |